Alpha 2 agonists in regional anaesthesia practice: Efficient yet safe?

[17] Investigational use of perineural or neuraxial dexmedetomidine without approval from DCGI may place the investigator, the institute and the review board at risk of medical malpractice litigations if there are drug related adverse events. [...]the safety of perineural and neuraxial dexmedetomidi...

Full description

Saved in:
Bibliographic Details
Published in:Indian journal of anaesthesia 2014-11, Vol.58 (6), p.681-683
Main Authors: Pankaj, Kundra, Rajan, P Sakthi
Format: Article
Language:English
Subjects:
Analgesics
Anesthesia
Cardiac arrhythmia
Drug dosages
FDA approval
Medical treatment
Meta-analysis
Methods
Neurotoxicity
Regional anesthesia
Studies
Surgery
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c626t-b1b3f32328e76c42e4d8b9140be22329ca497ad646c3583e7da0710c7cfa90a43
cites cdi_FETCH-LOGICAL-c626t-b1b3f32328e76c42e4d8b9140be22329ca497ad646c3583e7da0710c7cfa90a43
container_end_page 683
container_issue 6
container_start_page 681
container_title Indian journal of anaesthesia
container_volume 58
creator Pankaj, Kundra
Rajan, P Sakthi
description [17] Investigational use of perineural or neuraxial dexmedetomidine without approval from DCGI may place the investigator, the institute and the review board at risk of medical malpractice litigations if there are drug related adverse events. [...]the safety of perineural and neuraxial dexmedetomidine is clearly proven by further approved studies it is safe to avoid its use in neuraxial and perineural routes. [...]for the safe regional anaesthesia practice in patients receiving alpha 2 agonists as adjuvants to LA agents, one should monitor for bradycardia and hypotension, possible excess sedation and subsequent fall in haemoglobin saturation. [...]regulatory board approved and well powered safety studies for the use of perineural dexmedetomidine are available, it is safe to restrict its use in regional anaesthesia practice as an intravenous adjuvant to LA agents for its beneficial sedative and analgesic properties without respiratory depression.
doi_str_mv 10.4103/0019-5049.147127
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ff61d509f09d4337b9956e6246c10a11</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A395298683</galeid><doaj_id>oai_doaj_org_article_ff61d509f09d4337b9956e6246c10a11</doaj_id><sourcerecordid>A395298683</sourcerecordid><originalsourceid>FETCH-LOGICAL-c626t-b1b3f32328e76c42e4d8b9140be22329ca497ad646c3583e7da0710c7cfa90a43</originalsourceid><addsrcrecordid>eNptks1r3DAQxU1padK0956KoVB68VZflq0eWpaQtIFAL-1ZjOWRV4vX2lreQv77jLPJki2LDzaj3zzNPL8se8_ZQnEmvzDGTVEyZRZcVVxUL7JzZipdiJpXL-n76fgse5PSmjEppNavszNRaqFKYc6z62W_XUEucujiENKU8jDkI3YhDtDnMACmaYUpQL4dwU3B4df8yvvgAg5TfodTnsDj97fZKw99wneP74vsz_XV78ufxe2vHzeXy9vCaaGnouGN9DSEqLHSTglUbd0YrliDgqrGgTIVtFppJ8taYtUCqzhzlfNgGCh5kd3sddsIa7sdwwbGOxsh2IdCHDsLI03Zo_Ve87ZkxjPTKimrxphSI-2tHWfAOWl922ttd80GW0cLjdAfiR6fDGFlu_jPKmG0LBkJfH4UGOPfHRllNyE57HsYMO6S5boUxAo5z_3xP3QddyNZPFOK1bQx2XKgOqAFwuAj3etmUbuUhv5XrWtJVHGC6nBAGjIO6AOVj_jFCZ6eFjfBnWz49KxhhdBPqxT73UShSMcg24NujCmN6A_mcWbngNo5gXZOoN0HlFo-PDf90PCUSHkPK2LbeA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1640864632</pqid></control><display><type>article</type><title>Alpha 2 agonists in regional anaesthesia practice: Efficient yet safe?</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Medknow Open Access Medical Journals</source><source>PubMed Central</source><creator>Pankaj, Kundra ; Rajan, P Sakthi</creator><creatorcontrib>Pankaj, Kundra ; Rajan, P Sakthi</creatorcontrib><description>[17] Investigational use of perineural or neuraxial dexmedetomidine without approval from DCGI may place the investigator, the institute and the review board at risk of medical malpractice litigations if there are drug related adverse events. [...]the safety of perineural and neuraxial dexmedetomidine is clearly proven by further approved studies it is safe to avoid its use in neuraxial and perineural routes. [...]for the safe regional anaesthesia practice in patients receiving alpha 2 agonists as adjuvants to LA agents, one should monitor for bradycardia and hypotension, possible excess sedation and subsequent fall in haemoglobin saturation. [...]regulatory board approved and well powered safety studies for the use of perineural dexmedetomidine are available, it is safe to restrict its use in regional anaesthesia practice as an intravenous adjuvant to LA agents for its beneficial sedative and analgesic properties without respiratory depression.</description><identifier>ISSN: 0019-5049</identifier><identifier>EISSN: 0976-2817</identifier><identifier>DOI: 10.4103/0019-5049.147127</identifier><identifier>PMID: 25624529</identifier><language>eng</language><publisher>India: Medknow Publications and Media Pvt. Ltd</publisher><subject>Analgesics ; Anesthesia ; Cardiac arrhythmia ; Drug dosages ; FDA approval ; Medical treatment ; Meta-analysis ; Methods ; Neurotoxicity ; Regional anesthesia ; Studies ; Surgery</subject><ispartof>Indian journal of anaesthesia, 2014-11, Vol.58 (6), p.681-683</ispartof><rights>COPYRIGHT 2014 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications &amp; Media Pvt Ltd Nov-Dec 2014</rights><rights>Copyright: © Indian Journal of Anaesthesia 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c626t-b1b3f32328e76c42e4d8b9140be22329ca497ad646c3583e7da0710c7cfa90a43</citedby><cites>FETCH-LOGICAL-c626t-b1b3f32328e76c42e4d8b9140be22329ca497ad646c3583e7da0710c7cfa90a43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296350/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1640864632?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25624529$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pankaj, Kundra</creatorcontrib><creatorcontrib>Rajan, P Sakthi</creatorcontrib><title>Alpha 2 agonists in regional anaesthesia practice: Efficient yet safe?</title><title>Indian journal of anaesthesia</title><addtitle>Indian J Anaesth</addtitle><description>[17] Investigational use of perineural or neuraxial dexmedetomidine without approval from DCGI may place the investigator, the institute and the review board at risk of medical malpractice litigations if there are drug related adverse events. [...]the safety of perineural and neuraxial dexmedetomidine is clearly proven by further approved studies it is safe to avoid its use in neuraxial and perineural routes. [...]for the safe regional anaesthesia practice in patients receiving alpha 2 agonists as adjuvants to LA agents, one should monitor for bradycardia and hypotension, possible excess sedation and subsequent fall in haemoglobin saturation. [...]regulatory board approved and well powered safety studies for the use of perineural dexmedetomidine are available, it is safe to restrict its use in regional anaesthesia practice as an intravenous adjuvant to LA agents for its beneficial sedative and analgesic properties without respiratory depression.</description><subject>Analgesics</subject><subject>Anesthesia</subject><subject>Cardiac arrhythmia</subject><subject>Drug dosages</subject><subject>FDA approval</subject><subject>Medical treatment</subject><subject>Meta-analysis</subject><subject>Methods</subject><subject>Neurotoxicity</subject><subject>Regional anesthesia</subject><subject>Studies</subject><subject>Surgery</subject><issn>0019-5049</issn><issn>0976-2817</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptks1r3DAQxU1padK0956KoVB68VZflq0eWpaQtIFAL-1ZjOWRV4vX2lreQv77jLPJki2LDzaj3zzNPL8se8_ZQnEmvzDGTVEyZRZcVVxUL7JzZipdiJpXL-n76fgse5PSmjEppNavszNRaqFKYc6z62W_XUEucujiENKU8jDkI3YhDtDnMACmaYUpQL4dwU3B4df8yvvgAg5TfodTnsDj97fZKw99wneP74vsz_XV78ufxe2vHzeXy9vCaaGnouGN9DSEqLHSTglUbd0YrliDgqrGgTIVtFppJ8taYtUCqzhzlfNgGCh5kd3sddsIa7sdwwbGOxsh2IdCHDsLI03Zo_Ve87ZkxjPTKimrxphSI-2tHWfAOWl922ttd80GW0cLjdAfiR6fDGFlu_jPKmG0LBkJfH4UGOPfHRllNyE57HsYMO6S5boUxAo5z_3xP3QddyNZPFOK1bQx2XKgOqAFwuAj3etmUbuUhv5XrWtJVHGC6nBAGjIO6AOVj_jFCZ6eFjfBnWz49KxhhdBPqxT73UShSMcg24NujCmN6A_mcWbngNo5gXZOoN0HlFo-PDf90PCUSHkPK2LbeA</recordid><startdate>20141101</startdate><enddate>20141101</enddate><creator>Pankaj, Kundra</creator><creator>Rajan, P Sakthi</creator><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt Ltd</general><general>Wolters Kluwer Medknow Publications</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20141101</creationdate><title>Alpha 2 agonists in regional anaesthesia practice: Efficient yet safe?</title><author>Pankaj, Kundra ; Rajan, P Sakthi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c626t-b1b3f32328e76c42e4d8b9140be22329ca497ad646c3583e7da0710c7cfa90a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Analgesics</topic><topic>Anesthesia</topic><topic>Cardiac arrhythmia</topic><topic>Drug dosages</topic><topic>FDA approval</topic><topic>Medical treatment</topic><topic>Meta-analysis</topic><topic>Methods</topic><topic>Neurotoxicity</topic><topic>Regional anesthesia</topic><topic>Studies</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pankaj, Kundra</creatorcontrib><creatorcontrib>Rajan, P Sakthi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Databases</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Indian journal of anaesthesia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pankaj, Kundra</au><au>Rajan, P Sakthi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alpha 2 agonists in regional anaesthesia practice: Efficient yet safe?</atitle><jtitle>Indian journal of anaesthesia</jtitle><addtitle>Indian J Anaesth</addtitle><date>2014-11-01</date><risdate>2014</risdate><volume>58</volume><issue>6</issue><spage>681</spage><epage>683</epage><pages>681-683</pages><issn>0019-5049</issn><eissn>0976-2817</eissn><abstract>[17] Investigational use of perineural or neuraxial dexmedetomidine without approval from DCGI may place the investigator, the institute and the review board at risk of medical malpractice litigations if there are drug related adverse events. [...]the safety of perineural and neuraxial dexmedetomidine is clearly proven by further approved studies it is safe to avoid its use in neuraxial and perineural routes. [...]for the safe regional anaesthesia practice in patients receiving alpha 2 agonists as adjuvants to LA agents, one should monitor for bradycardia and hypotension, possible excess sedation and subsequent fall in haemoglobin saturation. [...]regulatory board approved and well powered safety studies for the use of perineural dexmedetomidine are available, it is safe to restrict its use in regional anaesthesia practice as an intravenous adjuvant to LA agents for its beneficial sedative and analgesic properties without respiratory depression.</abstract><cop>India</cop><pub>Medknow Publications and Media Pvt. Ltd</pub><pmid>25624529</pmid><doi>10.4103/0019-5049.147127</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0019-5049
ispartof Indian journal of anaesthesia, 2014-11, Vol.58 (6), p.681-683
issn 0019-5049
0976-2817
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_ff61d509f09d4337b9956e6246c10a11
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); Medknow Open Access Medical Journals; PubMed Central
subjects Analgesics
Anesthesia
Cardiac arrhythmia
Drug dosages
FDA approval
Medical treatment
Meta-analysis
Methods
Neurotoxicity
Regional anesthesia
Studies
Surgery
title Alpha 2 agonists in regional anaesthesia practice: Efficient yet safe?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T20%3A18%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alpha%202%20agonists%20in%20regional%20anaesthesia%20practice:%20Efficient%20yet%20safe?&rft.jtitle=Indian%20journal%20of%20anaesthesia&rft.au=Pankaj,%20Kundra&rft.date=2014-11-01&rft.volume=58&rft.issue=6&rft.spage=681&rft.epage=683&rft.pages=681-683&rft.issn=0019-5049&rft.eissn=0976-2817&rft_id=info:doi/10.4103/0019-5049.147127&rft_dat=%3Cgale_doaj_%3EA395298683%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c626t-b1b3f32328e76c42e4d8b9140be22329ca497ad646c3583e7da0710c7cfa90a43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1640864632&rft_id=info:pmid/25624529&rft_galeid=A395298683&rfr_iscdi=true